BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix

Connective Tissue Research

Volumn 47, Issue 5, 2006, Pages 271-277

  Behnam, K Keyvan ^a   Murray, Samuel S ^a,b   Brochmann, Elsa J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Bone morphogenetic protein; Demineralized bone matrix; Dermatopontin; Proteomics; TGF

Indexed keywords

ACTIN; ALKALINE PHOSPHATASE; DERMATOPONTIN; GAMMA ACTIN; HISTONE; HISTONE H2A2; HISTONE H2A3; HISTONE H2B; PROTEIN LYSINE 6 OXIDASE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SCLEROPROTEIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; CONTROLLED STUDY; ENZYME ACTIVATION; FUNCTIONAL PROTEOMICS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ALKALINE PHOSPHATASE; ANIMALS; BONE MATRIX; BONE MORPHOGENETIC PROTEINS; CELL LINE; EXTRACELLULAR MATRIX PROTEINS; GROWTH INHIBITORS; HISTONES; HUMANS; MICE; OSTEOBLASTS; OSTEOGENESIS; PROTEOCHONDROITIN SULFATES; PROTEOMICS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33751317492     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200600995908     Document Type: Article

References (26)

1. Urist, M. (1965) Bone: Formation by autoinduction Science, 150, pp. 893-899.
2. Wozney, J. and Rosen, V. and Celeste, A. and Mitsock, L. and Whitters, M. and Kriz, R. and Hewick, R. and Wang, E. (1988) Novel regulators of bone formation: Molecular clones and activities Science, 242, pp. 1528-1534.
3. Celeste, A. and Iannazzi, J. and Taylor, R. and Hewick, R. and Rosen, V. and Wang, E. and Wozney, J. (1990) Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone Proc. Natl. Acad. Sci. USA, 87, pp. 9843-9847.
4. Avsian-Kretchmer, O. and Hsueh, A. (2005) Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists Mol. Endocrinol, 18, pp. 1-12.
5. Rittenberg, B. and Partridge, E. and Baker, G. and Clokie, C. and Zohar, R. and Dennis, J. and Tenenbaum, H. (2005) Regulation of BMP-induced ectopic bone formation by Ahsg J. Orthop. Res., 23, pp. 6536-6562.
6. Behnam, K. and Phillips, M. and Silva, J. and Brochmann, E. and Duarte, M. and Murray, S. (2005) BMP binding peptide: A BMP-2 enhancing factor deduced from the sequence of native bovine bone morphogenetic protein/ non-collagenous protein J. Orthop. Res., 23, pp. 175-180.
7. Demetriou, M. and Binkert, C. and Sukhu, B. and Tenenbaum, H. and Dennis, J. (1996) Fetuin/1±2-HS glycoprotein is a TGF-β type II receptor mimic and cytokine antagonist J. Biol. Chem., 271, pp. 12755-12761.
8. Behnam, K. and Brochmann, E. and Murray, S. (2004) Alkali-urea extraction of demineralized bone matrix removes noggin, an inhibitor of bone morphogenetic proteins Connect. Tiss. Res., 45, pp. 257-260.
9. Okamoto, O. and Fujiwara, S. and Abe, M. and Sato, Y. (1999) Dermatopontin interacts with transforming growth factor β and enhances its biological activity Biochem. J, 337, pp. 537-541.
10. Urist, M. and Huo, Y. and Brownell, A. and Hohl, W. and Buyske, J. and Lietze, A. and Tempst, P. and Hunkapiller, M. and DeLange, R. (1984) Purification of bovine BMP by hydroxyapatite chromatography Proc. Natl. Acad. Sci. USA, 81, pp. 372-375.
11. Behnam, K. and Murray, S. and Whitelegge, J. and Brochmann, E. (2002) Identification of the molecular chaperone alpha B-crystallin in demineralized bone powder and osteoblast-like cells J. Orthop. Res., 20, pp. 1190-1196.
12. Behnam, K. and Murray, S. and Brochmann, E. (2005) Identification and characterization of valosin-contain protein (VCP/p97) in untransformed osteoblast-like cells J. Orthop. Res, 23, pp. 618-624.
13. Murray, S. and Murray, E. and Glackin, C. and Urist, M. (1993) Bone morphogenetic protein inhibits differentiation and affects expression of helix-loop-helix regulatory molecules in myoblastic cells J. Cell. Biochem, 53, pp. 51-60.
14. Han, B. and Tang, B. and Nimni, M. (2003) Quantitative and sensitive in vitro assay for osteoinductive activity of demineralized bone matrix J. Orthop. Res., 21, pp. 648-654.
15. Forbes, E. and Cronshaw, A. and MacBeath, J. and Hulmes, D. (1994) Tyrosine-rich acidic matrix protein (TRAMP) is a tyrosine-sulfated and widely distributed protein of the extracellular matrix FEBS Lett, 351, pp. 433-436.
16. Tallheden, T. and Karlsson, C. and Brunner, A. and Van Der Lee, J. and Hagg, R. and Tommasini, R. and Lindahl, A. (2004) Gene expression during redifferentiation of human articular chondrocytes Osteoarthr. Cart., 12, pp. 525-535.
17. Okamoto, O. and Suzuki, Y. and Kimura, S. and Shinkai, H. (1996) Extracellular matrix 22-kDa protein interacts with decorin core protein and is expressed in cutaneous fibrosis J. Biochem., 119, pp. 106-114.
18. MacBeath, J. and Shackelton, D. and Hulmes, D. (1993) Tyrosine-rich acidic matrix protein (TRAMP) accelerates collagen fibril formation in vitro J. Biol. Chem, 268, pp. 19826-19832.
19. Brown, D. and Vogel, K. (1989) Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen Matrix, 9, pp. 468-478.
20. Danielson, K. and Baribault, H. and Holmes, D. and Graham, H. and Kadler, K. and Iozzo, R. (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility J. Cell. Biol, 136, pp. 729-743.
21. Takeda, U. and Utani, A. and Wu, J. and Adachi, E. and Koseki, H. and Taniguchi, M. and Matsumoto, T. and Ohashi, T. and Sato, M. and Shinkai, H. (2002) Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis J. Invest. Dermatol, 119, pp. 678-683.
22. Cooper, L. and Bentley, A. and Nieduszynski, I. and Fullwood, N. and Ellis, T. and Thomson, A. and Utani, A. and Shinkai, H. and Brown, G. (2004) An ultrastructural investigation of DPT-knockout mouse corneas Intl. J. Exp. Path., 85, pp. A59.
23. Cooper, L. and Bentley, A. and Nieduszynski, I. and Talabani, S. and Thomson, A. and Utani, A. and Shinkai, H. and Fullwood, N. and Brown, G. (2006) The role of dermatopontin in the stromal organization of the cornea Invest. Opth. Vis. Sci.47, pp. 3303-3310.
24. Derfoul, A. and Perkins, G. and Hall, D. and Tuan, R. (2006) Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes Stem Cells, 24, pp. 1487-1495.
25. Kuroda, K. and Okamoto, O. and Shinkai, H. (1999) Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by TGF-β 1, IL-4 and matrix collagen J. Invest. Derm., 112, pp. 706-710.
26. Li, R. and Wozney, J. (2001) Delivering on the promise of bone morphogenetic proteins Trends Biotech. 19, pp. 255-265.